{"id":"W2158927044","doi":"10.1158/1078-0432.ccr-11-3284","title":"A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Sorafenib; Rash; Pharmacokinetics; Tolerability; Response Evaluation Criteria in Solid Tumors; Internal medicine; Pharmacodynamics; Refractory (planetary science); Adverse effect; Gastroenterology; Oncology; Pharmacology; Toxicity; Phases of clinical research; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001280492,0.0009228398,0.001551856,0.0001893365,0.0003077973,0.0004456244,0.0005754621,0.0006307317,0.001958019],"category_scores_gemma":[0.0008390469,0.0002992689,0.0008047095,0.0004422478,0.000808528,0.0004304988,0.0002852796,0.00242197,0.0003885046],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001019247,"about_ca_system_score_gemma":0.00277461,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001801758,"about_ca_topic_score_gemma":0.003965657,"domain_scores_codex":[0.9995217,0.0002436971,0.00003382274,0.00007435297,0.0000567337,0.00006973075],"domain_scores_gemma":[0.9989017,0.0001928894,0.0002851185,0.00007240978,0.00007362854,0.000474261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6126875,0.04480159,0.07339099,0.002126399,0.002984951,0.002053838,0.0009855093,0.007052013,0.08726124,0.0006805752,0.01496955,0.1510058],"study_design_scores_gemma":[0.5807551,0.3263956,0.06674876,0.00009948673,0.0007213344,0.002272073,0.0001520196,0.001944257,0.01036846,0.0001978602,0.01029832,0.00004679796],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939923,0.00192817,0.000558169,0.0004244549,0.00004025486,0.001212997,0.001077759,0.00004305072,0.0007227923],"genre_scores_gemma":[0.9858227,0.002618436,0.003875221,0.000765186,0.0001436481,0.002172715,0.003428528,0.00004458834,0.001128952],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001958019,"threshold_uncertainty_score":0.007395267,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2109089383653876,"score_gpt":0.5746474152749125,"score_spread":0.3637384769095249,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}